Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.47 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.47 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.44 |
| ▸ | CASR | P41180 | 2/20 | 0.43 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6254564 | 0.82 | LOXL2 (0.55) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 | |
| SCHEMBL13064053 | 0.77 | LOXL2 (0.49) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 | |
| SCHEMBL6252974 | 0.76 | LOXL2 (0.51) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 | |
| SCHEMBL31059889 | 0.76 | LOXL2 (0.69) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 | |
| SCHEMBL7169246 | 0.76 | LOXL2 (0.69) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 | |
| SCHEMBL14158511 | 0.76 | LOXL2 (0.56) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 | |
| SCHEMBL1724157 | 0.76 | LOXL2 (0.59) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 | |
| SCHEMBL28483740 | 0.74 | LOXL2 (0.53) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 | |
| SCHEMBL28335219 | 0.74 | LOXL2 (0.67) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 | |
| SCHEMBL28117187 | 0.74 | MTNR1A (0.51) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1814848-B9 | 2,3,4-SUBSTITUTED-CYCLOPENTANONES AS THERAPEUTIC AGENTS | ALLERGAN INC (US) | 2011-12-21 | — | — | EP | disclosed |
| EP-1814848-B1 | 2,3,4-SUBSTITUTED-CYCLOPENTANONES AS THERAPEUTIC AGENTS | ALLERGAN INC (US) | 2010-07-28 | — | — | EP | disclosed |